NexACT works as an anti-microbial preservative, says Apricus Bio
Apricus Bio’s NexACT drug delivery technology has qualified as an anti-microbial preservative, according to results from a US Pharmacopeia Preservative Efficacy Test (USP PET).
Archives for September 22, 2010
Pfizer plans more partnerships in Asia
The world’s biggest drugmaker, Pfizer, is set to bulk up its collaborative research partnerships with CROs and academics in Asia to lower costs and produce more affordable drugs.
Sun set on helping Taro, after buying controlling stake
India’s Sun Pharma has finally acquired a controlling stake in Israeli generics firm Taro Pharmaceutical Industries, significantly expanding its manufacturing capacity in North America.
EPO reengineered to cross mice BBB for neuroprotection
Reengineering erythropoietin (EPO) as an immunoglobulin G (IgG) fusion protein enables penetration of the blood-brain barrier (BBB) in mice, according to researchers.
CEE & Russia clinical trial initiation down 18% in 2009
Trials initiated in CEE and Russia fell 18 per cent year-on-year in 2009, ending a period of growth. Outsourcing-Pharma presents this rise and fall as an interactive visualisation.
DSM seeks Asian partners; welcomes J&J Crucell takeover
DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.
Oracle adds pharma PLM for drug development & production
Oracle is revising its lifecycle management package to streamline processes including scale-up to commercial production and QbD implementation.
GSK boosts vaccine and cancer units with tech licenses
GlaxoSmithKline (GSK) has entered into two unrelated development deals by signing license agreements for Delphi Genetics’ StabyExpress for its vaccine production operations and OncoMethylome Sciences’ DNA methylation specific PCR biomarkers for its...